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Introduction
Cell adhesion molecules (CAMs) signal across the plasma mem-
brane to process information from the extracellular environ-
ment. The mechanism of information transfer across the plasma 
membrane is known in some detail for integrins, which are 
heterodimeric transmembrane proteins (for review see Luo et al., 
2007). However, our knowledge about transmembrane signal-
ing mechanisms by homophilic cell–CAMs consisting of single 
polypeptide  chains,  such  as  cadherins  and  immunoglobulin- 
like (Ig) CAMs, is limited. Insights into these processes are im-
portant not only for understanding basic cell biological behav-
ior, but also because it has great impact on several medical and 
pathological conditions such as cancer, infection, and inflam-
mation. The focus of this study is to provide information on 
the mechanism and regulation of transmembrane signaling by a 
class of homophilic Ig CAMs.
One subfamily within the Ig CAM superfamily is the carcino-
embryonic antigen (CEA) family (Öbrink, 1997; Beauchemin   
et al., 1999), which plays important roles in a variety of cell-
based events, including morphogenesis (Yokoyama et al., 2007), 
vasculogenesis (Gu et al., 2009), angiogenesis (Horst et al., 2006), 
cell proliferation (Scheffrahn et al., 2005), cell motility (Klaile 
et al., 2005; Müller et al., 2005), apoptosis (Kirshner et al., 2003; 
Singer et al., 2005), tumor growth (Leung et al., 2008), invasion 
(Ebrahimnejad et al., 2004), infection, and inflammation (Gray-
Owen and Blumberg, 2006). The primordial molecule in the 
CEA family is CEA-related CAM1 (CEACAM1), a single-pass 
transmembrane type I glycoprotein, which is expressed as dif-
ferentially  spliced  isoforms  (Öbrink,  1997;  Gray-Owen  and 
Blumberg, 2006). The two major isoforms that differ only in 
their cytoplasmic domains but have identical transmembrane 
C
arcinoembryonic antigen (CEA)–related cell ad-
hesion molecule 1 (CAM1 [CEACAM1]) mediates 
homophilic cell adhesion and regulates signaling. 
Although  there  is  evidence  that  CEACAM1  binds  and   
activates SHP-1, SHP-2, and c-Src, knowledge about the 
mechanism of transmembrane signaling is lacking. To an-
alyze the regulation of SHP-1/SHP-2/c-Src binding, we 
expressed various CFP/YFP-tagged CEACAM1 isoforms 
in  epithelial  cells.  The  supramolecular  organization  of 
CEACAM1 was examined by cross-linking, coclustering, 
coimmunoprecipitation, and fluorescence resonance en-
ergy transfer. SHP-1/SHP-2/c-Src binding was monitored 
by coimmunoprecipitation and phosphotyrosine-induced 
recruitment to CEACAM1-L in cellular monolayers. We 
find  that  trans-homophilic  CEACAM1  binding  induces 
cis-dimerization by an allosteric mechanism transmitted 
by the N-terminal immunoglobulin-like domain. The bal-
ance of SHP-2 and c-Src binding is dependent on the 
monomer/dimer equilibrium of CEACAM1-L and is regu-
lated by trans-binding, whereas SHP-1 does not bind 
under physiological conditions. CEACAM1-L homodimer 
formation  is  reduced  by  coexpression  of  CEACAM1-S 
and modulated by antibody ligation. These data suggest 
that transmembrane signaling by CEACAM1 operates by 
alteration of the monomer/dimer equilibrium, which leads 
to changes in the SHP-2/c-Src–binding ratio.
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Cell  surface  expression  of  all  CEACAM1  constructs 
was verified by cytofluorimetry (unpublished data). Immunopre-
cipitation and Western blots of cellular lysates showed ex-
pression of a major band, corresponding to the size of wild-type 
CEACAM1 plus that of CFP/YFP and a smaller minor band for 
all CEACAM1 constructs (Fig. S1 B). Both bands reacted with 
anti-CEACAM1 and anti-GFP antibodies, suggesting that the 
smaller band represents an underglycosylated form. This isoform 
was apparently not expressed at the cell surface because it was 
not accessible for cross-linking in intact cells by a water-soluble 
cross-linking agent (Fig. 1 B).
Confocal microscopy demonstrated that the CEACAM1-
4L–YFP/CFP and CEACAM1-4S–YFP/CFP constructs became 
localized to cell contact areas in a pattern indistinguishable from 
that of wild-type CEACAM1 (Fig. S1 C). Also, N–CEACAM1-
3L–YFP and CEACAM1-4Cyto–YFP became localized to cell 
contact  areas.  Cotransfection  of  CEACAM1-4L–YFP  and 
CEACAM1-4S–CFP resulted in a complete codistribution of the 
two isoforms (Fig. S1 D).
Back-transfected CEACAM1 isoforms  
are functionally active
To  investigate  whether  the  reexpressed  YFP/CFP-tagged 
CEACAM1 isoforms were functionally active, we analyzed their 
ability to mediate homophilic adhesion. C2Dc3 cells expressing 
CEACAM1-4L–YFP,  CEACAM1-4S–YFP,  and  CEACAM1-
4Cyto–YFP but not N–CEACAM1-3L–YFP adhered effi-
ciently only to surfaces coated with rat CEACAM1-Fc (Fig. S2 A). 
The adhesion mediated by CEACAM1-4L–YFP/CEACAM1-
4S–YFP/CEACAM1-4Cyto–YFP  and  wild-type  CEACAM1 
required FBS and was partially inhibited by the tyrosine kinase 
inhibitor PP2 and strongly inhibited by the SHP-1/SHP-2 inhibi-
tor NSC-87877 (Fig. S2 B). The inhibitors did not alter the sur-
face expression of CEACAM1 (Fig. S2 D) or the cell viability 
because adhesion to collagen I was not affected (Fig. S2 C). These 
results show that the reexpressed CFP/YFP-tagged CEACAM1 
isoforms were functionally active and that homophilic cell adhe-
sion by CEACAM1 is an active process regulated by intracellular 
signaling events.
Supramolecular organization of CEACAM1 
in the plasma membrane
Previous work has demonstrated that endogenous CEACAM1 
can form cross-linkable dimers in the plane of the plasma mem-
brane (Hunter et al., 1996). Cross-linking of the back-transfected 
cells with a water-soluble cross-linker showed that all YFP-tagged 
isoforms of CEACAM1 appeared as a mixture of monomers, a 
significant proportion of dimers, and a small fraction of larger 
oligomers,  which  is  comparable  with  wild-type  CEACAM1 
(Fig. S1 E). Similar levels of cross-linked dimers occurred in 
both adherent, contacting cells, and in suspended single cells 
(Fig. 1 B), suggesting that the stabilized dimers represented cis-
dimers. This was directly demonstrated by the finding that trans-
dimers were not stabilized by cross-linking as determined in an 
experiment in which cells expressing wild-type CEACAM1 
and CEACAM1-4LCyto–YFP were mixed, allowed to adhere 
to each other, and subjected to cross-linking. No YFP reactivity 
domains and ectodomains consisting of four Ig domains are 
CEACAM1-4L  and  CEACAM1-4S.  In  most  CEACAM1- 
expressing cell types, CEACAM1-4L and CEACAM1-4S are 
coexpressed, albeit at different ratios in different cell types (Singer 
et al., 2000; Gaur et al., 2008). In CEACAM1-L, two phosphor-
ylatable tyrosine residues play an important role in signaling. 
Upon phosphorylation, these tyrosine-based sequences can bind 
and activate the cytoplasmic protein tyrosine phosphatases SHP-1/
SHP-2 (Huber et al., 1999) and Src family tyrosine kinases 
(Brümmer et al., 1995). Recent studies have implicated these 
enzymes, which compete for the same phosphotyrosine-binding 
sites as major effectors in CEACAM1-L–mediated signaling 
(Boulton and Gray-Owen 2002; Singer et al., 2005; Nagaishi 
et al., 2006; Slevogt et al., 2008).
CEACAM1 signal regulation is influenced by its adhesion-
mediating homophilic trans-binding activity (Gray-Owen and 
Blumberg, 2006). However, the nature of the transmembrane 
signal that is triggered by the trans-homophilic binding is un-
known. We have suggested that it involves changes in the dimer-
ization state (Öbrink et al., 2002) and have recently been able to   
show that trans-homophilic binding between membrane-attached 
CEACAM1 ectodomains indeed increases cis-dimerization (see 
Klaile et al. on p. 553 of this issue). In this study, we set out to 
investigate whether a similar mechanism operates in the plasma 
membrane of viable epithelial cells. The results demonstrate 
that transmembrane signaling by CEACAM1-L is a function of 
its lateral interactions, which determine the binding proportions 
of SHP-1, SHP-2, and c-Src to the CEACAM1-L cytoplasmic 
domains. The state of the CEACAM1-L supramolecular orga-
nization is regulated both by CEACAM1 trans-homophilic cell 
adhesion and by the expression level of CEACAM1-S and can 
be modulated by antibodies.
Results
Silencing and reexpression of CEACAM1  
in NBT-II cells
NBT-II cells were chosen because they express endogenous 
CEACAM1 and contain an appropriate response machinery 
for CEACAM1-mediated signal regulation (Scheffrahn et al., 
2005). To express reporter-labeled CEACAM1 isoforms, en-
dogenous  CEACAM1  was  permanently  down-regulated  by 
stable transfection with a vector coding for a short hairpin 
RNA (shRNA) targeting exon 9. In the most efficiently down-
regulated clones, endogenous CEACAM1 was undetectable 
by  cytofluorimetry  (not  depicted)  or  Western  blotting,  and 
other CAMs such as 3 and 6 integrins and E-cadherin were 
unaffected (Fig. S1 A). One clone, C2Dc3, was chosen for fur-
ther experiments.
In addition to full-length CEACAM1-4L and CEACAM1-4S, 
two truncated CEACAM1 molecules were reexpressed in C2Dc3 
cells, namely N–CEACAM1-3L and CEACAM1-4Cyto, 
which lacked the N-terminal Ig domain (D1) or the cytoplasmic 
domain, respectively. To allow monitoring and fluorescence reso-
nance energy transfer (FRET) analysis, monomeric CFP or YFP 
(Kim et al., 2003) was inserted between the fourth Ig domain (D4) 
and the transmembrane domain in all of the constructs (Fig. 1 A).571 Discriminatory binding of SHP-1/SHP-2/Src by CEACAM1 • Müller et al.
was detected by immunoprecipitation with an anti–L-cytoplasmic 
domain antibody (Fig. 1 C).
To  collect  further  information  on  the  nature  of  cis- 
dimerization, two additional sets of experiments were performed. In 
one experiment, silenced cells were cotransfected with CEACAM1- 
4S–CFP and N–CEACAM1-3L–YFP. CEACAM1-4S–CFP was 
clustered with mAb 5.4 (directed against the N-terminal domain) 
and secondary antibodies. This resulted in coclustering of   
N–CEACAM1-3L–YFP (Fig. 1 D). In the other experiment, 
silenced cells were cotransfected with either CEACAM1-4S–CFP 
and N–CEACAM1-3L–YFP or CEACAM1-4Cyto–YFP and 
N–CEACAM1-3L–YFP. Immunoprecipitation with the anti– 
L-cytoplasmic domain antibody, recognizing N–CEACAM1-
3L–YFP,  resulted  in  coprecipitation  of  CEACAM1-4S–CFP 
and  CEACAM1-4Cyto–YFP  (Fig.  1  E).  Both  experiments 
demonstrate that CEACAM1 molecules can interact with each 
other in cis through Ig domains D2–D4 and/or via their trans-
membrane domains.
Characterization of CEACAM1  
cis-interactions by FRET
Cis-interactions of CEACAM1 were further analyzed by FRET 
microscopy.  Acceptor  photobleaching  was  used  to  measure 
FRET both in contact regions and free edges of cells attached to 
poly-L-lysine–coated glass coverslips (Fig. 2 A). Insignificant 
FRET signals (FRET efficiency [E] = 0.60 ± 0.96%) were ob-
served  in  contacts  between  cells  that  were  monotransfected 
with  CEACAM1-4L–CFP  and  CEACAM1-4L–YFP,  demon-
strating that the observed FRET in cotransfected cells emanated 
from cis-interactions in the plane of the plasma membrane and 
not from adhesion-mediating CEACAM1 in trans.
Efficient  FRET  at  cell  edges  was  observed  with 
CEACAM1-4L/CEACAM1-4L, CEACAM1-4S/CEACAM1-
4S,  and  CEACAM1-4L/CEACAM1-4Cyto  combinations 
(Fig.  2  B).  Pairs  of  ∆N–CEACAM1-3L/CEACAM1-4L  and   
∆N–CEACAM1-3L/CEACAM1-4S exhibited strikingly lower 
FRET efficiencies (Fig. 2 B), showing that the N-terminal Ig domain 
has an important and dominating role in these cis-interactions, 
Figure  1.  Homophilic  CEACAM1  cis-interactions  in  the  plasma  mem-
brane. (A) Graphic representation of reexpressed CEACAM1 isoforms/
mutants in C2Dc3 cells. CFP (blue) or YFP (yellow) was inserted between 
the  membrane  proximal  Ig  domain  and  the  transmembrane  domain.   
(B) Cross-linking of CEACAM1-4L–YFP in confluent monolayer (c) and sus-
pended (s) cells with BS
3. M, monomer; D, dimer. (C) Wild-type NBT-II   
cells  expressing  CEACAM1-S  and  CEACAM1-L  were  cocultured  with 
CEACAM1-4Cyto–YFP-expressing cells at a 3:1 ratio, grown to conflu-
ence, and cross-linked. CEACAM1-L was immunoprecipitated either with 
anti–cytoplasmic domain (cyto) or anti-GFP antibodies. The immunopre-
cipitates were analyzed for GFP reactivity (left) or CEACAM1 reactivity 
(right) by Western blotting (WB). No GFP immunoreactivity was detected 
in  the  CEACAM1-L  precipitates,  even  after  prolonged  exposure  on   
x-ray films. (D) CEACAM1-4S–CFP-expressing cells were transiently trans-
fected with N–CEACAM1-3L–YFP and seeded on poly-L-lysine–coated 
coverslips. CC1-S-CFP was clustered with mAb 5.4 and goat anti–mouse 
antibodies. The cells were fixed and analyzed for the distribution of CC1-
S-CFP (a and d, red) and N-CC1-YFP (b and e, green). Merged images 
(c and f) show coclustering (yellow) of the two CEACAM1 isoforms. Bars,   
10 µm. (E) Lysates of C2Dc3 cells expressing CEACAM1-4Cyto–YFP (C), 
N–CEACAM1-3L–YFP (N), or coexpressing CEACAM1-4S–YFP/N–
CEACAM1-3L–YFP  (S:N)  or  CEACAM1-4Cyto–YFP/N–CEACAM1-
3L–YFP (C:N) were immunoprecipitated with CEACAM1-L cytoplasmic 
domain–specific antibodies. (top) N domain–containing CEACAM1 molecules 
in complex with L-cytoplasmic domain–containing proteins were detected 
by  immunoblotting  with  mAb  Be9.2.  (bottom)  Filters  were  reprobed 
with CC16 for detection of precipitated CEACAM1. (right) Immuno-
precipitation with anti–cyclin D1 was used as rabbit IgG control. IP, immuno-
precipitation; MW, molecular weight.
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and Edidin, 1998; Zacharias et al., 2002), these results show 
that CEACAM1-4L and CEACAM1-4S occur as mixtures of 
randomly distributed monomers and specifically microclustered 
cis-dimers and/or small cis-oligomers in the free cell edges.
The FRET signals were different in the cell contact re-
gions. In contrast to the behavior in free cell edges, there was no 
dependence on the acceptor density (Fig. 2 F). This relationship 
of FRET efficiency and acceptor intensity has been expressed as 
a saturable one-site binding model,
     E = Emax × F/(F + K),         (1)
whereas the cytoplasmic domains do not contribute signifi-
cantly. The FRET efficiency of CEACAM1-4L/CEACAM1-4L 
(not depicted) and CEACAM1-4S/CEACAM1-4S in the free 
cell edges decreased with increasing uD/A (postbleach CFP 
intensity/prebleach YFP intensity) ratios (Fig. 2 C). Plotting 
the FRET efficiency against acceptor fluorescence intensity at 
different uD/A ratios showed decreasing FRET efficiency with 
an increasing uD/A ratio (Fig. 2 D). Furthermore, at a given 
uD/A ratio, the FRET efficiency in the free cell edges increased 
smoothly and showed a curvy linear dependence on acceptor 
density (Fig. 2 E). According to current FRET theory (Kenworthy 
Figure 2.  CEACAM1 cis-interactions determined 
by FRET. (A) Images of CFP and YFP fluorescence 
of contacting cells expressing CEACAM1-4L–CFP 
and CEACAM1-4L–YFP before and after YFP 
bleaching.  Note  the  disappearance  of  YFP 
fluorescence and increase of CFP fluorescence 
(in the boxed areas) after bleaching. Bars, 10 
µm. (B) FRET efficiencies (mean ± SD) in free 
cell edges of the indicated pairs of coexpressed 
CEACAM1 isoforms at a 0.6–1.0 uD/A ratio 
and acceptor intensity of 80–110. *, P < 0.0001   
(Student’s t test). (C) FRET efficiency plotted ver-
sus uD/A ratio for free edges of cells expressing 
CEACAM1-4S–CFP/CEACAM1-4S–YFP (n = 14; 
four ROIs per cell). (D) FRET efficiency plotted 
versus acceptor fluorescence at different uD/A 
ratios for the same 14 cells as in C. (E and F) 
FRET in free cell edges (E) and contact regions   
(F)  for  CEACAM1-4L–CFP/CEACAM1-4L–YFP-
expressing cells at a 0.6–1.0 uD/A ratio. The 
least-square  fits  of  the  experimental  data  to 
Eq. 1 are shown as red curves with 95% confi-
dence intervals shown as flanking blue curves. 
The fitted value for K ± SD is shown for each 
graph. (G) Comparison of FRET efficiencies at 
free edges and contact regions for similar pairs 
of coexpressed CEACAM1 as in B. The uD/A   
ratios, acceptor intensity ranges, and p-values 
(Student’s t test) are shown for each pair.573 Discriminatory binding of SHP-1/SHP-2/Src by CEACAM1 • Müller et al.
increased K value (Fig. 4, A and B). This indicates that 5.4 had a 
dissociating effect on the CEACAM1 microclusters, thereby 
increasing the monomer fraction. mAb Be9.2 had an opposite 
effect and induced increased concentration-dependent micro-
clustering in free edges, as manifested by a higher Emax value 
(Fig. 4 C). However, the K value remained the same as in unper-
turbed cells. A polyclonal anti-CEACAM1 antibody (CC16) 
caused macroclustering of CEACAM1 on the cell surface (un-
published data). FRET analysis showed increased microcluster-
ing within these macroclusters with significantly lower K and 
higher Emax (Fig. 4 D). mAb Be9.2, but not 5.4, also increased 
the  FRET  efficiency  in  CEACAM1/CEACAM1-positive  cell 
contact areas of confluent cells (Fig. 4 E). These results suggest 
that both CC16 and Be9.2 induced a different kind of lateral 
association than those occurring in unperturbed cells. Support 
for this interpretation was obtained from size determination 
by sucrose gradient centrifugation (Fig. 4 F). Cells expressing 
CEACAM1-4L–YFP or CEACAM1-4Cyto–YFP were incu-
bated with 5.4, Be9.2, or CC16, solubilized in 1% Brij 58, and 
subjected to sedimentation rate centrifugation on discontinuous 
sucrose  gradients. This  demonstrated  that  both  Be9.2  and 
CC16, but not 5.4, induced formation of larger complexes of 
both  CEACAM1-4L–YFP  (not  depicted)  and  CEACAM1-
4Cyto–YFP (Fig. 4 F).
CEACAM1-L can bind SHP-1, SHP-2,  
and c-Src in a discriminatory manner
In the continued analyses, we focused on the first downstream 
event in the CEACAM1-L signaling process, which is binding 
of SHP-1/SHP-2 tyrosine phosphatases and c-Src tyrosine 
kinase to its tyrosine-phosphorylated cytoplasmic domain. In 
contrast to hematopoietic cells in which sustained tyrosine 
phosphorylation is achieved by homophilic binding or antibody 
ligation, CEACAM1-L is generally only transiently phosphory-
lated in epithelial cells under the influence of not well-defined 
growth factors (Huber et al., 1999; Chen et al., 2008). Therefore, 
where E is a hyperbolic function of the cell surface density (F), 
and K is analogous to a dissociation constant of the microclus-
ters (Zacharias et al., 2002). A K value can be obtained by curve 
fitting of the FRET data to Eq. 1. However, the obtained K does 
not represent a true dissociation constant, especially because the 
data represent a mixture of different proportions of randomly 
distributed molecules and microclusters. Nevertheless, K val-
ues obtained under different conditions can be compared with 
yield information on the tendency to form microclusters; the 
lower the K value, the greater the tendency to cluster. Fitting of 
the data in Fig. 2 (E and F) yielded a drastically lower K value 
for FRET in cell contacts compared with FRET in free cell 
edges, demonstrating that CEACAM1-4L and CEACAM1-4S   
in the cell contact regions occur predominantly as microclus-
tered assemblies.
The  FRET  efficiencies  in  free  edges  and  cell  contacts 
were determined for different CEACAM1 isoform combina-
tions (Fig. 2 G). At low acceptor levels, the CEACAM1-4L/
CEACAM1-4L,  CEACAM1-4S/CEACAM1-4S,  CEACAM1-
4L/CEACAM1-4S,  and  CEACAM1-4∆Cyto/CEACAM1-4S 
combinations  showed  higher  FRET  efficiency  in  the  cell 
contacts  than  in  the  free  edges,  which  is  in  contrast  to  the 
∆N–CEACAM1-3L/CEACAM1-4L  and  ∆N–CEACAM1-3L/
CEACAM1-4S  combinations  that  showed  an  opposite  trend 
with lower FRET signals in contact regions compared with free   
edges. These results indicate that homophilic CEACAM1 trans-
binding in cell contact areas, mediated by the N-terminal domain, 
induces increased CEACAM1 cis-dimerization/oligomerization 
in the plane of the plasma membrane.
mAbs perturb the organization of 
CEACAM1 in the plasma membrane
Next, we investigated the effects of two different mAbs (Be9.2 
and 5.4) that recognize different, nonoverlapping epitopes in the 
N-terminal CEACAM1 Ig domain with comparable affinities 
(see Materials and methods; Fig. S4). mAbs Be9.2 and 5.4 had 
completely opposite effects on homophilic adhesion mediated 
by  CEACAM1-4L–YFP  (Fig.  3  A),  CEACAM1-4S–YFP 
(not depicted), or CEACAM1-4Cyto–YFP (not depicted).   
Although Be9.2 blocked adhesion, 5.4 caused a significant 
stimulation. The 5.4-stimulated adhesion was not caused by 
passive bridging between cell surface–exposed CEACAM1 and 
CEACAM1 on the substrate surface because the antibody did 
not cause attachment of cells that were treated with NSC-87877, 
which in itself blocked adhesion but did not decrease the sur-
face expression of CEACAM1 as demonstrated by cytofluor-
imetry (Fig. S2 D). Thus, the differential effects on adhesion by 
the two mAbs probably reflect specific alterations of the confor-
mation and/or supramolecular organization of the CEACAM1 
ectodomains. Neither antibody had any effect on attachment to 
collagen I (Fig. 3 B).
To investigate whether the antibodies affected the supra-
molecular organization of CEACAM1, we determined the 
FRET efficiency in CEACAM1-4L–CFP/CEACAM1-4L–YFP-
expressing cells (Fig. 4, A–E). In comparison with unstimulated 
cells, mAb 5.4 induced a more linear response of the FRET effi-
ciency in free edges, which is also manifested by the slightly   
Figure 3.  Modulation of homophilic cell adhesion by mAbs. (A and B) 
CEACAM1-4L–YFP-expressing cells were plated in rat CEACAM1-Fc (A)– 
or collagen I (B)–coated dishes for 2 h in the presence of 10% FBS with or 
without (c) mAb 5.4, mAb Be9.2, control IgG (concentrations in parenthe-
ses are given in microgram/milliliter), and the SHP-1/SHP-2 inhibitor NSC-
87877. In some cases, CEACAM1-Fc–coated dishes were preincubated 
(pre) with the indicated antibodies. Attached cells were detected by crystal 
violet staining. The data represent mean ± SD of a representative experi-
ment (n = 3) performed in triplicate. $, statistical significance compared 
with c; $, *, P < 0.005 (Student’s t test).JCB • VOLUME 187 • NUMBER 4 • 2009   574
more pronounced for SHP-2 than for SHP-1 (Fig. 5 C). Pull-
down experiments with c-Src did not show preferential binding 
of dimers (unpublished data).
Coexpression of CEACAM1-L and 
CEACAM1-S influences the binding  
of SHP-1 and SHP-2
Because CEACAM1-L and CEACAM1-S can form hetero-
dimers  (Fig.  1,  D  and  E),  we  reasoned  that  coexpression 
of CEACAM1-S with a constant level of CEACAM1-L would   
decrease the level of the CEACAM1-L cytoplasmic domain in   
dimer configuration. Using antibodies recognizing the cytoplasmic 
domain of CEACAM1-L, we demonstrated that the expression   
level of CEACAM1-4L–YFP remained the same in cells that were 
cotransfected with CEACAM1-4S–YFP (Fig. 5 D). Immunoprecip-
itation of c-Src did not bring down any CEACAM1-L. However, 
significantly lower amounts of CEACAM1-L were coprecipitat-
ing with both SHP-1 and SHP-2 when CEACAM1-4S–YFP was 
coexpressed with CEACAM1-4L–YFP (Fig. 5 D). The reduction   
of  coprecipitating  CEACAM1-L  was  more  pronounced  for 
SHP-2 than for SHP-1, which is in agreement with the pull-down 
experiments that demonstrated that SHP-2 had a stronger ten-
dency for binding CEACAM1-L dimers than SHP-1.
Recruitment of SHP-1, SHP-2, and c-Src 
to CEACAM1-L at the plasma membrane
To determine whether discriminatory binding occurs in intact 
cells, we investigated the colocalization patterns of these en-
zymes with CEACAM1-L in subconfluent monolayers made 
to induce a sustained tyrosine-phosphorylated state, we incu-
bated the NBT-II cells with pervanadate. Pervanadate-treated, 
suspended cells were lysed in 1% Brij 58 and immunoprecipi-
tated with polyclonal CC16 or the monoclonal Be9.2 and 5.4. 
Although  SHP-1/SHP-2/c-Src  did  not  coprecipitate  with 
CEACAM1-4S–YFP,  all  three  enzymes  coprecipitated  with 
CEACAM1-4L–YFP (Fig. 5, A and B). Significant amounts of 
both SHP-1 and SHP-2 were coprecipitated in unstimulated 
cells by all three antibodies. Only a small amount of c-Src was 
coprecipitated by the pAb and by 5.4, whereas Be9.2 did not co-
precipitate any c-Src at all. Because this indicated that the differ-
ent antibodies could selectively regulate binding of the different 
enzymes to CEACAM1-L, we prestimulated the cells with the 
antibodies before solubilization. Similar to unstimulated cells, 
prestimulation with polyclonal CC16 resulted in coprecipita-
tion of all three enzymes. However, prestimulation with 5.4 in-
creased c-Src coprecipitation and decreased coprecipitation of 
SHP-1, whereas coprecipitation of SHP-2 was unchanged. Pre-
stimulation with Be9.2 caused a minor coprecipitation of c-Src 
but moderately increased SHP-1 coprecipitation and resulted in 
a more-pronounced coprecipitation of SHP-2 (Fig. 5, A and B).
Because these results indicated that the lateral supra-
molecular organization of CEACAM1-L might be a factor that 
regulates its cytoplasmic interactions, we investigated the binding 
abilities of CEACAM1-L monomers and dimers. Cross-linked 
CEACAM1-L–expressing cells were solubilized and subjected 
to pull-down experiments with GST–SHP-1 and GST–SHP-2.   
Both  SHP-1  and  SHP-2  bound  CEACAM1-L  dimers  much 
stronger than monomers, and the preferred dimer binding was 
Figure  4.  Perturbation  of  CEACAM1  orga-
nization by anti-CEACAM1 antibodies. (A–D) 
FRET  for  CEACAM1-4L–CFP/CEACAM1-4L–
YFP-expressing cells at a 0.5–1.2 uD/A ratio. 
(A) Untreated cells are shown. (B–D) Incuba-
tion with mAb 5.4 (B), mAb Be9.2 (C), and 
pAb CC16 (D). The least-square fits of the 
experimental data to Eq. 1 are shown as red 
curves, with 95% confidence intervals shown 
as flanking blue curves. The fitted values for 
K and Emax are given for each graph. (E) FRET 
(mean ± SD) of mixed cultures of nonexpress-
ing and CEACAM1-4L–CFP/CEACAM1-4L–
YFP-expressing cells. Contact regions between 
nonexpressing  and  CEACAM1-expressing 
cells (no CC1 in trans; 1.1–1.48 uD/A ratio; 
acceptor  intensity  of  17–24)  and  between 
mutually CEACAM1-expressing cells (CC1 in 
trans; 0.61–0.81 uD/A ratio; acceptor inten-
sity of 34–56) were analyzed. $, P = 0.397; 
§, P = 0.094; *, P ≤ 0.0027 (Student’s t test). 
(F) Sedimentation rate analysis of CEACAM1 
after antibody treatment. Suspensions of single 
cells expressing CEACAM1-4Cyto–YFP were 
untreated (control) or incubated with mAb 5.4, 
mAb Be9.2, or pAb CC16. Postnuclear ly-
sates were loaded on top of a sucrose step 
gradient and centrifuged for 2 h at 105,000 
g. 12 fractions (1–12; top to bottom) were col-
lected from the top and analyzed by immuno-
blotting  for  CEACAM1  and  E-cadherin. 
Representative  blots  from  three  different  ex-
periments are shown. Black lines indicate that 
intervening lanes have been spliced out. MW, 
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+/ contacts, thus mimicking trans-homophilic CEACAM1-L 
binding (Fig. 6 C).
To induce a more-pronounced reorganization by the mAbs 
and the Fc fusion protein, secondary antibodies were added for 
20 min to induce macroclustering of CEACAM1-L (Fig. 7). 
During this short incubation time, no significant endocytic up-
take of the CEACAM1 clusters occurred. CEACAM1-4–Fc 
clustered CEACAM1 mainly at free cell edges with little re-
arrangement in cell contact regions. Also, mAb 5.4 led to large 
cluster formation at free cell edges but left CEACAM1 in the 
contact regions essentially intact. mAb Be9.2 induced a pro-
nounced macroclustering both in cell contact regions and in 
other locations of the cells. Upon tyrosine phosphorylation, the 
CEACAM1-Fc–induced CEACAM1-L macroclusters recruited 
SHP-2 strongly, SHP-1 weakly, and c-Src not at all (Fig. 7 B). 
Clustering by mAb 5.4 induced a low level recruitment of 
SHP-2 but had very little effect on SHP-1 or c-Src (Fig. 7 B). 
In contrast, clustering by mAb Be9.2 induced a pronounced re-
cruitment of SHP-1, a low level recruitment of c-Src, and an 
even lower recruitment of SHP-2. (Fig. 7 B).
We next investigated whether antibody treatment induced 
membrane subcompartmentalization of CEACAM1 and SHP-1/
SHP-2. Clustering with Be9.2, but not with 5.4 or CEACAM1-Fc   
(unpublished data), significantly increased the association of 
CEACAM1-L with detergent-insoluble membrane material in-
dependent of the tyrosine phosphorylation status (Fig. 7 C). A 
striking corecruitment of SHP-1 but not SHP-2 into the Be9.2-
induced detergent-insoluble membrane fraction occurred after 
induction of tyrosine phosphorylation (Fig. 7 C).
Discussion
CEACAM1 regulates cell signaling in a cell contact–dependent 
manner (Scheffrahn et al., 2005; Gray-Owen and Blumberg, 2006).   
from mixed CEACAM1-expressing and -nonexpressing cells, 
which allowed simultaneous monitoring of contact zones of   
CEACAM1/CEACAM1-expressing (+/+), CEACAM1-expressing/ 
nonexpressing  (+/),  and  CEACAM1-nonexpressing/ 
nonexpressing (/) cells. Pervanadate treatment induced a strong 
tyrosine phosphorylation of all cell contact areas (not depicted) 
and resulted in a significant recruitment and colocalization of 
SHP-2, but not of SHP-1, in CEACAM1-4L–YFP +/+ contacts 
(Fig. 6, A and B). A less-pronounced recruitment of c-Src was 
also observed in some +/+ contacts (Fig. 6, A and B). In cells 
expressing N–CEACAM1-3L–YFP, the recruitment of SHP-2 
to +/+ contacts was reduced to <50% of that recruited to full-
length CEACAM1-4L–YFP (Fig. 6 B). The recruitment patterns 
for c-Src did not change significantly in the N–CEACAM1-
3L–YFP +/+ contacts, demonstrating that c-Src recruitment to 
CEACAM1-L was not dependent on trans-homophilic binding 
by the N-terminal Ig domain (Fig. 6 B). Recruitment of SHP-2 to 
CEACAM1-4L–YFP +/ contacts was strongly reduced to the 
same levels as seen for N–CEACAM1-3L–YFP +/+ and +/ 
contacts (Fig. 6 B), and the recruitment of c-Src to +/ contacts 
was reduced to the same background levels as seen in / con-
tacts (Fig. 6 B).
Incubation of the cell cultures with mAbs and soluble 
CEACAM1-4–Fc fusion protein had no effects on SHP-1 (not 
depicted) but selectively affected recruitment of SHP-2 and   
c-Src to cell contact–localized CEACAM1-4L–YFP (Fig. 6 C). 
Thus, mAb 5.4 enhanced the recruitment of c-Src to both +/+ 
and +/ contacts. It had no significant effect on SHP-2 in +/+ 
contacts but significantly increased SHP-2 recruitment to +/ 
contacts. Adhesion-blocking mAb Be9.2 also stimulated the re-
cruitment of c-Src to +/+ and +/ contacts, whereas it reduced 
recruitment of SHP-2 to +/+ and had no effect on +/ contacts. 
CEACAM1-4–Fc had very little effect on SHP-2 recruitment to 
+/+ contacts but dramatically increased SHP-2 recruitment to 
Figure  5.  Discriminatory  binding  of  c-Src, 
SHP-1, and SHP-2 to CEACAM1-L. (A) Suspen-
sions of CEACAM1-4L–YFP or CEACAM1-4S–
YFP-expressing cells were untreated or incubated 
with mAb 5.4, mAb Be9.2, pAb CC16, or 
control  IgG,  treated  with  pervanadate,  and 
lysed in Brij 58. Postnuclear supernatants were 
immunoprecipitated by antibodies coupled to 
protein G–Sepharose (untreated cells) or plain 
protein  G–Sepharose  (prestimulated  cells). 
Immunoprecipitates  were  immunoblotted  for 
tyrosine phosphorylation (PY99), CEACAM1 
(Be9.2), or coprecipitating c-Src, SHP-1, and 
SHP-2. (B) Quantification of the amount of en-
zymes coprecipitated with CEACAM1-4L–YFP 
shown in A. (C) Suspensions of CEACAM1-
4S–YFP- or CEACAM1-4L–YFP-expressing cells 
were incubated with pervanadate, cross-linked 
with  BS
3,  and  lysed.  SHP-1–  and  SHP-2– 
interacting proteins were affinity precipitated 
by GST–SHP-1 or GST–SHP-2 bound to gluta-
thione Sepharose. Monomeric (M) and dimeric 
(D) CEACAM1 were detected by immunoblot-
ting with Be9.2. Ratios of detected dimers to 
monomers (D/M) are shown below the blots. (D) CEACAM1-4L–YFP-expressing cells were mock transfected () or transiently transfected with CEACAM1-
4S–YFP (+), incubated for 48 h, treated with pervanadate, and lysed. Lysates were immunoprecipitated with CEACAM1-L cytoplasmic domain–specific 
antibodies (Cyt-L) or with antibodies against SHP-1, SHP-2, or c-Src. CEACAM1 was detected by Be9.2, SHP-1, SHP-2, and c-Src with their respective   
antibodies. The ratios of CEACAM1-L precipitated in the absence and presence of coexpressed CEACAM1-S (mean ± SD of three independent experi-
ments) are shown below the blots. IP, immunoprecipitation; WB, Western blotting; MW, molecular weight.JCB • VOLUME 187 • NUMBER 4 • 2009   576
coclustering, and coimmunoprecipitation showed that Ig do-
mains  D2–D4,  and  maybe  the  transmembrane  domain, 
participate in cis-binding, FRET determinations demonstrated 
that Ig domain D1 also exhibits a strong, mutual cis-interaction. 
Furthermore, the FRET experiments revealed that antiparallel 
D1-mediated trans-homophilic binding between CEACAM1 
molecules in cell junctions triggered increased cis-interactions 
between these molecules, which agrees with our recent find-
ings in proteoliposomes (Klaile et al., 2009). Thus, both the 
liposome experiments and the present data indicate that the 
N-terminal Ig domain transmits allostery that is important for 
adhesion-triggered rearrangements of the lateral organization 
of CEACAM1.
CEACAM1 does not occur either as monomers, dimers, 
or oligomers in different parts of the plasma membrane but as a 
mixture of these species. The relative proportions of CEACAM1 
monomers, dimers, and oligomers are regulated by the expres-
sion level and by trans-homophilic binding in cell junctions. 
In addition, the expression ratio of the cytoplasmic domain 
isoforms CEACAM1-L and CEACAM1-S is an important reg-
ulator of the monomer/dimer state of the cytoplasmic domain 
of  CEACAM1-L  because  CEACAM1-L  and  CEACAM1-S 
form heterodimers.
The first downstream event in signaling by CEACAM1-L is 
binding and activation of SH2 domain carrying tyrosine phos-
phatases and kinases to its tyrosine-phosphorylated cytoplas-
mic domain. In this study, we have investigated the nature of 
the transmembrane processes that regulate these binding inter-
actions. We show that CEACAM1-L occurs in a state of dynamic 
equilibrium between monomers, dimers, and oligomers and can 
discriminate between binding of SHP-1, SHP-2, and c-Src as a 
function of changes in this equilibrium. We further demonstrate 
that the CEACAM1-L association state equilibrium is regulated 
by homophilic CEACAM1 trans-binding, by expression of the 
smaller isoform CEACAM1-S, and by mAbs directed against 
the CEACAM1 N-terminal Ig domain.
Regulation of the supramolecular 
organization of CEACAM1
Truncation of the N-terminal D1 Ig domain of CEACAM1 
showed that it mediates homophilic adhesion by reciprocal   
antiparallel binding, which is in agreement with previous work 
(Wikström et al., 1996). In addition, all CEACAM1 isoforms 
in  the  plasma  membrane  participated  in  lateral  cis-binding   
interactions that were mediated by the ectodomain and/or the   
transmembrane  domain.  Although  chemical  cross-linking,   
Figure 6.  CEACAM1-L–mediated recruitment of SHP-2 and c-Src. Mixed cultures of nonexpressing and CEACAM1-4L–YFP-expressing cells or non-
expressing and N–CEACAM1-3L–YFP-expressing cells were grown in monolayers; +/+, CEACAM1/CEACAM1-expressing contacts; +/, CEACAM1- 
expressing/nonexpressing contacts; /, nonexpressing/nonexpressing contacts. (A) CEACAM1-4L–YFP was detected by YFP fluorescence; SHP-2, 
SHP-1, and c-Src were detected by indirect immunofluorescence (merge, false colors; red, YFP; green, Alexa Fluor 546). Nontreated cells (a–c) and   
pervanadate-treated cells (d–l) are shown. Bars, 10 µm. (B) Quantification of cell contact recruitment of SHP-2, SHP-1, and c-Src after pervanadate treatment 
(percentage of positively stained contacts). (C) Mixed cultures of nonexpressing and CEACAM1-4L–YFP-expressing cells were untreated (c) or incubated 
with mAb Be9.2, mAb 5.4, or CEACAM1-Fc before pervanadate treatment. Quantification was performed as described in B. (B and C) Numbers of 
analyzed contacts (n) are shown on top of each bar. Statistical significance was calculated using the two-proportion z test. *, P ≤ 0.0003; **, P ≤ 0.001;   
$, P ≤ 0.2; §, P ≤ 0.1.577 Discriminatory binding of SHP-1/SHP-2/Src by CEACAM1 • Müller et al.
Discriminatory binding of SHP-1,  
SHP-2, and c-Src is determined by the 
supramolecular organization of CEACAM1-L
One of the important findings in the present investigation was 
that CEACAM1-L could discriminate between binding of c-Src, 
SHP-1, and SHP-2 in a manner that was regulated and dependent 
on its supramolecular organization. The discriminatory binding 
of the three enzymes might be the basis for the different signal 
regulatory effects by CEACAM1, which have been found   
to be both inhibitory and stimulatory (Greicius et al., 2003; 
Scheffrahn et al., 2005; Gray-Owen and Blumberg, 2006; Slevogt 
et al., 2008). The relative binding proportions of the enzymes 
depended on the state of lateral associations of CEACAM1-L 
and were controlled by CEACAM1 trans-homophilic bind-
ing in cell junctions. As outlined in the model in Fig. 8, the   
allosterically induced microclustering of CEACAM1 will bring 
the cytoplasmic domains of CEACAM1-L molecules in close 
proximity, which will lead to intensified interactions with cyto-
plasmic phosphatases upon tyrosine phosphorylation and to 
subsequent changes of the ratio of bound SHP-1/SHP-2 and 
c-Src. In general, SHP-2 was the predominant binding partner 
for CEACAM1-L in NBT-II cells in which it was recruited to 
essentially all CEACAM1-L–containing cell junctions upon 
induction of tyrosine phosphorylation. This is in contrast to   
hematopoietic cells in which SHP-1 seems to be the primary bind-
ing and signaling partner (Singer et al., 2005; Nagaishi et al., 
2006). The preferred binding of SHP-2 over SHP-1 may partly 
result from the higher affinity of SHP-2 for dimeric CEACAM1-L 
but may most likely be the result of different compartmentaliza-
tion of the two phosphatases. SHP-1 and SHP-2 differ in their 
These findings do not completely agree with our previous 
model in which we suggested that trans-homophilic adhesion 
is mediated by monomeric CEACAM1 and that cis-dimeric 
CEACAM1 occurs on surfaces that are not engaged in cell–cell 
adhesion (Öbrink et al., 2002). This model was based on the 
limited biochemical/cell biological data that were available at 
that time, and one of the aims of this study was to produce ex-
perimental data that would show the role of CEACAM1 mono-
mers  and  cis-dimers  in  cell  adhesion.  Together  with  the 
accompanying paper (Klaile at al., 2009), we can now demon-
strate that adhesion is mediated both by monomeric and cis- 
dimeric CEACAM1 and that trans-homophilic binding triggers 
increased cis-dimerization. One prediction of the previous model, 
which we now demonstrate to be true, was that coexpression   
of CEACAM1-S and CEACAM1-L would decrease the extent of 
CEACAM1-L  cis-homodimerization  caused  by  formation  of 
CEACAM1-L/CEACAM1-S cis-heterodimers. Another pre-
diction, based on molecular modeling, was that monomeric 
CEACAM1-L would favor SHP-1/SHP-2 binding, whereas di-
meric CEACAM1-L would favor c-Src binding. However, the 
experimental data demonstrate that the tyrosine phosphatases 
prefer dimeric CEACAM1-L, whereas c-Src does not show any 
particular preference for dimeric over monomeric CEACAM1-L. 
SHP-1/SHP-2 has two SH2 domains, both of which can bind   
to either of the two phosphotyrosine-based binding sequences 
in the cytoplasmic domain of CEACAM1-L (Sigmundsson,   
2004).  The  preference  of  the  phosphatases  for  dimeric 
CEACAM1-L might thus be caused by simultaneous binding to 
two CEACAM1-L molecules, which was suggested previously 
(Öbrink and Hunter, 1998).
Figure 7.  Superclustering of CEACAM1 and recruitment of c-Src, SHP-1, and SHP-2. (A) CEACAM1-4L–YFP-expressing cells were incubated with rat 
CEACAM1-Fc, mAb 5.4, or mAb Be9.2 followed by anti–human Fc IgG or anti–mouse IgG. The cellular localization of CEACAM1-4L–YFP (a, d, g,   
and j), SHP-1 (k), and SHP-2 (b, e, and h) was analyzed by confocal microscopy. Merged images (c, f, i, and l) demonstrate colocalization of SHP-2 
with CEACAM1-Fc–induced clusters and SHP-1 with Be9.2-induced clusters (red, SHP-1/SHP-2; green, false-color YFP). Bars, 10 µm. (B) Quantification of   
c-Src, SHP-1, and SHP-2 colocalized with CEACAM1-4L–YFP clusters. (C) Immunoblots of detergent-insoluble material after clustering of CEACAM1-L–YFP. 
C2Dc3- or CEACAM1-L–YFP-expressing cells were untreated () or preincubated (+) with primary antibodies for 20 min and secondary antibodies for 20 
or 50 min. Pervanadate (PV) was added (+) during the last 5 min. The cells were lysed in ice-cold 1% Triton X-100/HBSM, and the insoluble material was 
analyzed for CEACAM1, SHP-1, SHP-2, and -actin. MW, molecular weight.JCB • VOLUME 187 • NUMBER 4 • 2009   578
Thus, it is obvious that CEACAM1 participates in a complex 
network of cellular control mechanisms.
The supramolecular organization and 
cytoplasmic interactions of CEACAM1 can 
be perturbed by antibodies
Two mAbs directed against different epitopes in the N-terminal 
Ig domain had opposite effects both on CEACAM1-mediated 
homophilic adhesion and on lateral CEACAM1 interactions in 
the plasma membrane. The differential effects suggest that the 
two mAbs stabilize different conformations, which is in agree-
ment with the allosteric regulation of the homophilic binding 
activities of the N-terminal Ig domain. Ligation with mAb 5.4 
increased the trans-homophilic adhesion and at the same time 
led to a reduction of CEACAM1 microclustering. In contrast, 
mAb Be9.2 inhibited trans-binding but induced a higher level 
of microclustering. The blocking effect of mAb Be9.2 was 
partly overcome by simultaneous ligation with mAb 5.4, indi-
cating that the epitope-mediating trans-adhesion was not simply 
shielded by Be9.2. mAb Be9.2 therefore seems to induce a con-
formation of the N domain that is no longer suitable for trans-
homophilic binding. In addition, the two antibodies affected the 
interactions with c-Src, SHP-1, and SHP-2 in strikingly differ-
ent ways. However, the antibody effects were different in intact 
and solubilized cells. The coprecipitation patterns in solubilized 
cells, which reflect the average interactions of all CEACAM1-L,   
indicate which types and levels of interactions that can occur. The 
recruitment patterns observed in intact cells show which types of 
interactions that do occur with CEACAM1-L organized in cell 
junctions, which is different from what can occur, presumably 
because of different compartmentalization of the enzymes. Cross-
linking of the primary mAbs with secondary antibodies induced a   
pronounced rearrangement of CEACAM1-L on the cell surface 
and a dramatic change in the recruitment of SHP-1/SHP-2/c-Src   
(Fig. 7). The almost-exclusive recruitment of SHP-1 to CEACAM1-L   
super clustered by mAb Be9.2 might be explained by colocal-
ization of the two molecules in lipid rafts because supercluster-
ing with mAb Be9.2 but not with mAb 5.4 caused association of 
CEACAM1-L with detergent-resistant membrane domains. The 
activating mechanism for recruitment of SHP-1 remains elusive 
at present, but it has been shown that serine phosphorylation of its   
C terminal can regulate the cytoplasmic/nuclear/raft localization 
(Liu et al., 2007). The almost exclusive recruitment of SHP-2 
to CEACAM1-L super clustered by CEACAM1-Fc was most 
likely caused by mimicking of CEACAM1-L trans-homophilic 
binding. The different effects of the mAbs make CEACAM1 a 
potentially interesting but also challenging target for mAb-based 
therapy of human disease.
Materials and methods
Reagents and antibodies
All  reagents  were  obtained  from  Sigma-Aldrich  or  Merck  if  not  stated 
otherwise. Anti–rat CEACAM1 mouse monoclonal (Be9.2 and 5.4) and 
rabbit polyclonal (CC16 and anti–CEACAM1-L–Cyto [cyto]) antibodies 
were described previously (Becker et al., 1986; Singer et al., 2000; Budt   
et al., 2002). All antibodies recognized monomeric and dimeric CEACAM1-L   
equally well (Fig. S3). The mAbs Be9.2 and 5.4 recognized different, non-
overlapping epitopes in the N-terminal Ig domain of rat CEACAM1 as 
C-terminal amino acid sequences (Poole and Jones, 2005), and 
SHP-1 has a bipartite nuclear localization (Craggs and Kellie, 
2001) motif and a short sequence responsible for targeting to 
lipid rafts (Sankarshanan et al., 2007), both of which are miss-
ing in SHP-2. Thus, SHP-1 may not be available for binding to 
dimeric CEACAM1-L in cell junctions.
Because  the  monomer/dimer/oligomer  balance  can  be 
regulated by the cell, it seems likely that CEACAM1 does not 
operate as an on/off switch but rather regulates cell signaling in 
a context-dependent, continuous manner. Because both of the 
total expression level and the CEACAM1-S/CEACAM1-L ex-
pression ratios vary considerably between various cell types, 
between different functional states of the same cell type, during 
different phases of the cell cycle, and between normal and cancer 
cells (Singer et al., 2000, 2002; Gaur et al., 2008), it confers on 
CEACAM1 a broad potential in regulating a variety of outside-in 
signaling events. In addition, we found that the extracellular 
recognition activities of CEACAM1 itself can be controlled by 
unidentified factors in FBS and by intracellular tyrosine kinase/
phosphatase-regulated reactions. Because the cytoplasmic tail 
of CEACAM1 was dispensable in this context, it is unlikely that 
phosphorylation/dephosphorylation events within this domain 
regulate the affinity of the extracellular domain in an inside-out 
signaling process. Rather, it implicates cytoplasmic events down-
stream of cytokine/growth factor receptor activation, which   
either involve cytoskeletal rearrangements or modifications of   
a hitherto unidentified lateral binding partner of CEACAM1. 
Figure 8.  A model for transmembrane signaling by CEACAM1-L. Trans-
  homophilic binding mediated by the N-terminal Ig domain induces cis- 
dimerization of CEACAM1 by an allosteric mechanism. Cis-homodimerization   
of CEACAM1-L brings its cytoplasmic domains together, which interact 
to change the relative binding affinities for SHP-2 and c-Src. Therefore, 
increased CEACAM1-L homodimerization results in increased binding/ 
activation of SHP-2 but no change or a slightly reduced binding/activation 
of c-Src. The displayed recruitment data for SHP-2 and c-Src are calculated 
from the data presented in Fig. 6 B.579 Discriminatory binding of SHP-1/SHP-2/Src by CEACAM1 • Müller et al.
Cell adhesion
Cell adhesion measurements were performed as described previously (Müller 
et al., 2005). In brief, 96-well plates (Maxisorb immuno plate; Thermo 
Fisher Scientific) were coated with 50 µl rat D(1–4)-Fc (80 µg/ml), rat 
D(2–4)-Fc (80 µg/ml), human D(1–4)-Fc (80 µg/ml), BSA (10 mg/ml), or 
rat tail collagen I (20 µg/ml) overnight at 4°C blocked with 1% BSA/PBS 
for 1 h at 37°C and washed with PBS. Cells were grown to 70% conflu-
ency and trypsinized; trypsin was inhibited with soybean trypsin inhibitor 
(Roche). For analyzing the effect of serum, the cells were serum starved 1 h 
before trypsination. 3 × 10
4 cells per well were seeded in the absence or 
presence of the following inhibitors and antibodies: 10 µM PP2, 100 µM 
NSC-87877, 4–40 µg/ml mAbs 5.4 and Be9.2, and isotype control IgG 
(anti-huCD56). In the analyses of the SHP inhibitor NSC-87877, the cells 
were cultured in 50 µg/ml NSC-87877 for 2 d before adhesion determi-
nation. Cells were allowed to attach for 2 h (at 37°C in 5% CO2), and 
nonattached cells were removed by washing. Attached cells were fixed 
(4% PFA/PBS) and stained with 0.1% crystal violet, bound crystal violet 
was extracted with 0.5% Triton X-100/H2O, and the OD was determined 
at 595 nm.
Immunoprecipitation and immunoblotting
Immunoprecipitation. Trypsinized, suspended cells in serum-free me-
dium were incubated with or without 40 µg/ml antibodies for 10 min fol-
lowed  by  0.1  mM  pervanadate  for  5  min  at  37°C  and  collected  by 
centrifugation. Adherent cells were incubated with 0.1 mM pervanadate 
for 5 min at 37°C and scraped into lysis buffer. Pelleted and scraped cells 
were lysed immediately with ice-cold HBSM (25 mM Hepes, 150 mM 
NaCl, and 2 mM MgCl2, pH 7.2)/1% Brij 58 supplemented with protease 
(Sigma-Aldrich)  and  phosphatase  inhibitor  cocktails  (PhosStop;  Roche),   
1 mM PMSF, and 0.1 mM pervanadate. After 1 h on ice, the lysates were 
cleared by centrifugation at 15,000 g, and equal amounts of protein, de-
termined by the BCA method (Thermo Fisher Scientific), were immunopre-
cipitated by protein A–Sepharose or protein G–Sepharose beads plain or 
precoupled with 2–3 µg antibodies for 2–3 h at 4°C. After washing (three 
times in HBSM/0.1% Brij 58), the beads were boiled in Laemmli sample 
buffer and subjected to SDS-PAGE and immunoblotting.
Analysis of detergent-insoluble membranes. Cells were incubated with 
10 µg/ml primary antibodies (at 37°C for 20 min) and 10 µg/ml second-
ary antibodies (at 37°C for 20 or 50 min) and lysed with ice-cold 1%   
Triton X-100/HBSM for 1 h. Insoluble material was pelleted by centrifuga-
tion at 17,000 g for 10 min. Pellets were washed with HBSM and boiled 
in 2× Laemmli buffer. After digestion of DNA with Benzonase (Sigma- 
Aldrich), equal volumes were analyzed by immunoblotting.
Immunoblotting.  Electrophoretically  separated  components  were 
transferred to nitrocellulose filters (Schleicher & Schüll). HRP-conjugated 
secondary antibodies were detected by ECL (SuperSignal West Pico 
Chemiluminescent Substrate; Thermo Fisher Scientific) using a digital system 
(LAS-1000; Fujifilm) or films (BioMax MS; Kodak). Quantification was per-
formed in the Image Gauge software (Fujifilm) or on films scanned and an-
alyzed with the ImageJ software (National Institutes of Health). Images 
were imported into Photoshop (Adobe) for processing.
Chemical cross-linking and pull-down
Adherent or trypsinized cells were washed with serum-containing medium 
and PBS supplemented with 1 mM CaCl2/2 mM MgCl2 (PBS/Mg/Ca) at 
RT. Cross-linking was initiated by addition of 0.5 mg/ml bis-sulfosuccinimi-
dyl suberate (BS
3) freshly prepared in PBS/Mg/Ca. After 15 min, the reac-
tion was quenched with 50 mM Tris/HCl in PBS, pH 7.9, and the cells 
were lysed for 1 h in 2% Triton X-100/0.2% SDS/HBSM supplemented 
with protease/phosphatase inhibitor cocktails, 1 mM PMSF, and 0.1 mM 
pervanadate. The lysates were cleared by centrifugation at 15,000 g and 
analyzed  for  CEACAM1  by  SDS-PAGE/immunoblotting.  For  GST  pull-
down experiments, cells were washed and incubated with 0.1 mM per-
vanadate in PBS (for 5 min at 37°C), pelleted, resuspended in PBS/BS
3,   
cross-linked, and lysed in 2% Triton X-100/0.2% SDS/HBSM. Cleared 
lysates were diluted 1:2 with HBSM, and equal volumes were incubated 
with 4 µg GST-tagged SHP-1 or SHP-2 (precoupled to glutathione Sepha-
rose) for 3 h at 4°C. The beads were washed three times with 0.1% Triton 
X-100/HBSM and boiled in Laemmli SDS sample buffer. Affinity-purified 
proteins were analyzed and detected by immunoblotting.
Sedimentation analysis
Subconfluent NBT-II cells expressing CEACAM1-4L–YFP or CEACAM1-
4Cyto–YFP were trypsinized and incubated in serum-free medium with or 
without 40 µg/ml antibodies for 10 min at 37°C. The cells were pelleted and 
determined by BIAcore-binding analysis but had similar binding affinity 
toward cell surface–expressed CEACAM1 (Fig. S4). Other mouse mAbs 
used were anti-CD56 (T199; Dako), anti-Src (B-12; Santa Cruz Biotechnol-
ogy, Inc.), anti–3-integrin (clone 42; BD), anti–E-cadherin (clone 34; BD), 
anti–6-integrin (4E9G8; DPC Biermann), and anti-GFP (clones 7.1 and 
13.1; Roche). The following primary pAbs were used: rabbit anti-SHP-1 
(C-19), rabbit anti–SHP-2 (C-18), rabbit anti-Src (N-16), rabbit anti–cyclin 
D1 (C-20; Santa Cruz Biotechnology, Inc.), and rabbit antiactin (20–33; 
Sigma-Aldrich). The following secondary antibodies were used: goat anti–
mouse IgG Alexa Fluor 546 and 488 conjugates, goat anti–rabbit IgG Al 
exa Fluor 633, 546, and 488 conjugates (Invitrogen), unconjugated and   
peroxidase-conjugated goat anti–mouse, and goat anti–rabbit IgG (Jackson   
ImmunoResearch Laboratories, Inc.).
Cell culture, cloning, and expression procedures
Culture reagents were obtained from Invitrogen. Rat bladder carcinoma-
derived epithelial NBT-II cells (Toyoshima et al., 1971) were grown at 
37°C in 5% CO2 in high glucose DME/10% FBS/penicillin/streptomycin 
and 500 µg/ml G418 and/or 10–40 µg/ml Blasticidin S if indicated. 
Transfections were performed using Lipofectamine 2000 (Invitrogen), and 
cloning was performed by limited dilution. Correct sequences and reading 
frames of all constructs were verified by sequencing.
Rat CEACAM1 shRNA vector. Rat CEACAM1 shRNA targeting nucleo-
tides  1,446–1,464  in  rat  CEACAM1  (annealed  5-GGTGGATGACGTCTCAT-
ACTTCAAGAGAGTATGAGACGTCATCCACCTTTTTT-3  and  5-AATTA-
AAAAAGGTGGATGACGTCTCATACTCTCTTGAAGTATGAGACGTCATC-
CACCGGCC-3; Edlund et al., 1993) was expressed under the U6 pro-
moter of pSilencer (Applied Biosystems) in pEGFP-N1 (the EGFP cassette 
was removed; Takara Bio Inc.).
Recombinant transmembrane rat CEACAM1.  Rat  CEACAM1-4L  and 
CEACAM1-4S cDNAs (Olsson et al., 1995) were inserted into the XbaI–
HindIII sites of pcDNA3(+) (Invitrogen). The cDNAs of monomeric CFP and 
YFP (Kim et al., 2003) were provided by T. Springer (Harvard Medical 
School, Boston, MA), amplified by PCR (Phusion polymerase; Finnzyme; 
5-CCTGATCCAACACAAGGAAATTCTGGCCTCTCAGGAGGTGGCATGG-
TGAGCAAGGGC-3 and 5-AGATCCAATCACAATGCCTGCAATGGCA-
CCCTCTGATCCTCCTCCCTTGTACAGCTCGTC-3), and were inserted by 
homologous recombination into the extracellular domain between mem-
brane proximal serine (S422) and glutamic acid (E423) residues (-G-L-S-
CFP/YFP-E-G-A-; Edlund et al., 1993) flanked by 3-Gly linkers. Silent mu-
tations in the CEACAM1 sequence used for the shRNA were introduced 
by amplification of the plasmid (5-GTGAGCTATTCTGTCCTGAACTTCAA-
TGC-3 and 5-ATCGTCGACCTTGTTAGGAGAGTCGT-3) and self-ligation.   
To obtain vectors with Blasticidin resistance, the XbaI–HindIII cassettes of 
CEACAM1-CFP/YFP constructs were ligated into pcDNA6/V5a (Invitro-
gen).  To  obtain  CEACAM1-4Cyto–YFP,  pcDNA6/CEACAM1-4L–YFP 
was amplified and self-ligated using the primers 5-TAGAAGAAGTGA-
CATTGTCTGTCCTG-3 and 5-ATAAAGGAAGTATGCCAGCGCT-3 to in-
troduce a stop codon terminating the polypeptide chain at Y448. To obtain 
N–CEACAM1-3L–YFP, pcDNA6/CEACAM1-4L–YFP was amplified and 
self-ligated  using  the  primers  5-GGTGACTTGGGCAGTGGT-3  and   
5-GCATTACAAAAGCCCAACGTC-3 (omitting the D1 domain).
Soluble CEACAM1 ectodomains. For the rat and human D(1–4)-Fc con-
structs, rat and human CEACAM1 ectodomains (GenBank accession 
no. J04963 and X16354) and human IgG Fc (GenBank accession no.   
BC014258) were amplified (rat CEACAM1, 5-AAGCTTTAGCAGGCAG-
CAGAGACTATGG-3  and  5-GAATTCAGAATTTCCTTGTGTTGGATC-
AGG-3;  human  CEACAM1,  5-AAGCTTACCATGGGGCACCTCTCA-
GCC-3 and 5-GAATTCAGGTGAGAGGCCATTTTCTTG-3; and human Fc, 
5-GAATTCATGGCACCTGAACTCCTGGGGGGACC-3 and 5-CTCGA-
GTCATTTACCCGGAGACAGGGAGAGGC-3)  and  ligated  sequentially 
into the HindIII–EcoRI–XhoI sites of pcDNA3.1(+) (Invitrogen). To obtain 
the rat D(2–4)-Fc construct, the vector containing rat D(1–4)-Fc was ampli-
fied (5-GGTGACTTGGGCAGTGGT-3 and 5-GCATTACAAAAGCCCA-
ACGTC-3; omitting the D1 domain) and self-ligated. Plasmids were trans-
fected into HEK293 cells, and proteins were allowed to accumulate in   
serum-free Pro293s-CDM medium (BioWhittaker). Fc fusion proteins were 
purified by protein A–Sepharose affinity chromatography (HiTrap Protein 
A HP; GE Healthcare).
Recombinant  phosphatases.  GST-tagged  catalytically  inactive   
mouse  SHP-1  (C>S)  and  SHP-2  in  pGEX-2TK  were  provided  by   
N.  Beauchemin  (McGill  University,  Montreal,  Quebec,  Canada).  Re-
combinant proteins were expressed in Escherichia coli BL21 (DE3)pLysS 
and purified by affinity chromatography on glutathione Sepharose 4 
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lysed in 1% Brij 58/HBSM supplemented with protease inhibitor cocktail 
and 1 mM PMSF for 1 h at 4°C. The lysates were centrifuged at 15,000 g,   
200 µl supernatants was loaded on top of discontinuous gradients made 
from 1 ml each of 48, 35, 25, 17, 10, and 3% (wt/wt) sucrose/HBSM, 
and were centrifuged at 100,000 g for 120 min in an ultracentrifuge rotor 
(70.1 Ti; Beckman Coulter). 516 µl fractions was collected from the top, 
and equal volumes were analyzed by SDS-PAGE/immunoblotting.
Immunofluorescence and confocal microscopy
For colocalization experiments, cells were seeded sparsely on coverslips 
and grown for 2 d to 70% confluence. After serum starvation (1 h), anti-
bodies (20 µg/ml) were added for 30 min at 37°C or in clustering experi-
ments for 20 min plus 20-min secondary antibodies (10 µg/ml). The cells 
were incubated with 0.1 mM pervanadate (for 5 min at 37°C), fixed in 4% 
PFA/PBS  (10  min),  permeabilized  in  4%  PFA/PBS/0.025%  saponin   
(10 min), blocked with 1% BSA/PBS (1 h), and incubated with primary   
antibodies (5 µg/ml) for 2 h or overnight and with appropriate secondary 
antibodies (1:200) for 2 h. For coclustering of CEACAM1 isoforms, cells 
were seeded sparsely in the presence of 20 µg/ml primary anti-CEACAM1 
antibodies (for 1 h at 37°C) on poly-L-lysine–coated coverslips, and incu-
bated with secondary antibodies for 20 min at 37°C before fixation. The 
coverslips were mounted in Vectashield (Vector Laboratories) and sealed 
with nail polish. Confocal images were recorded in a laser-scanning con-
focal inverse microscope (Axiovert 200; Carl Zeiss, Inc.) equipped with   
argon, HeNe1, and HeNe2 lasers and a detector system (LSM 510 META; 
Carl Zeiss, Inc.) with a 63× NA 1.4 Plan Apochromat (Carl Zeiss, Inc.) or 
a 40× NA 0.75 Plan Neofluar objective (Carl Zeiss, Inc.). Images were 
imported from the LSM 5 Image Examiner software (version 3.2; Carl 
Zeiss, Inc.) into Photoshop (Adobe) for processing.
FRET
Cells  stably  transfected  with  one  CFP/YFP-tagged  donor/acceptor 
CEACAM1  isoform  were  transiently  transfected  with  a  complementary 
CFP/YFP-tagged donor/acceptor isoform, and FRET was measured by ac-
ceptor photobleaching of fixed cells 24–48 h after the transient transfec-
tion. Both cultured, adherent cells and trypsinized cells that were plated for 
90 min in serum-containing medium on coverslips coated with 0.002% 
poly-L-lysine or Matrigel (1:100 in PBS) were examined. The attached cells 
were incubated with or without 20 µg/ml antibodies for 20 min at 37°C, 
fixed with 4% PFA/PBS for 10 min at RT, and mounted in Vectashield. 
Fields containing one to four cells were chosen, and prebleach images of 
CFP and YFP were collected separately with a 40× NA 0.75 oil immersion 
objective. CFP was excited at 458 nm with 35.1% laser intensity emission 
and detected at 475–500 nm with detector gain of 955; YFP was excited 
at 514 nm with 3% laser intensity and detected at 530–560 nm with detec-
tor gain of 610. A selected region of interest (ROI) was photobleached 
with the 514-nm laser line (100% intensity; 100–140 iterations), and post-
bleach CFP and YFP images were collected. After image registration and 
background subtraction, the fluorescent signal outlining the cell membrane 
was divided into 5–15 ROIs per cell that were each analyzed indepen-
dently in the ImageJ or the LSM 510 software (Carl Zeiss, Inc.). Selected 
ROIs exhibiting saturation in either the donor or acceptor channel were 
eliminated from further analysis. For FRET analysis of cell contact regions, 
contacting cells with similar intensity levels of CFP and YFP were chosen, 
and the relative intensities for each fluorophor were divided by two to ob-
tain fluorescence signals originating from one plasma membrane only. 
FRET efficiency (E) was calculated as E (%) = 100 x [1  (FCFPpre/FCFPpost)], 
where FCFPpre and FCFPpost are the mean CFP emission intensities before and 
after  YFP  photobleaching,  respectively.  Data  were  fitted  to  Eq.  1  (see   
Results) by a least-squares procedure using IGOR Pro (version 6.0; Wave-
Metrics, Inc.).
Online supplemental material
Fig. S1 shows CEACAM1 knockdown in C2Dc3 cells by stable transfection 
with shRNA and analysis of reexpressed, YFP-tagged CEACAM1 isoforms 
by  immunoblotting,  confocal  microscopy,  and  chemical  cross-linking.  Fig.  S2   
shows the ability of CEACAM1-YFP isoforms expressed in NBT-II cells 
to  mediate  homophilic  adhesion,  the  effect  of  kinase  and  phospha-
tase  inhibitors  on  adhesion,  and  the  effect  of  inhibitors  and  anti-
CEACAM1  antibodies  on  surface  expression  levels  of  CEACAM1. 
Fig. S3 shows the recognition of monomeric and dimeric CEACAM1 
by  various  anti-CEACAM1  antibodies.  Fig.  S4  shows  the  binding  of 
mAbs Be9.2 and 5.4 to cell surface–exposed CEACAM1 by flow cy-
tometry. Online supplemental material is available at http://www.jcb 
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